Contents

Search


acetylcholine (nicotinic) Ab antibody in serum

Indications: - evaluation of myasthenia gravis Clinical significance: - occurs in patients with myasthenia gravis (MG). - occasionally occur in association with: a) amyotrophic lateral sclerosis (ALS) b) Lambert-Eaton myasthenic syndrome c) pernicious anemia - does NOT occur with congenital myasthenia gravis - occurs in only 15% of patients with ocular myasthenia gravis Specimen: 1) serum 2) store refrigerated or frozen without preservative 3) do NOT use plasma 4) stable at -20 degrees C Normal range: < 0.03 nmol/L Method: Radioimmunoassay (RIA) False positives may occur with muscle relaxants: 1) metocurine 2) succinylcholine Acetylcholine receptor antibody is more sensitive for detection of MG than electromyography (EMG) & is useful for following the response of MG to therapy. If negative & clinical suspicion of MG is high, acetylcholine receptor blocking & acetylcholine receptor modulating antibodies are used as 2nd & 3rd line tests.

Specific

acetylcholine (nicotinic) receptor binding Ab in serum acetylcholine (nicotinic) receptor modulating Ab in serum

General

serology

References

  1. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 651
  2. Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995

Component-of

Acetylcholine receptor modulating Ab/Acetylcholine receptor Ab total in Serum